跳至主要内容
临床试验/NCT03673306
NCT03673306已完成不适用

A Multicenter Retrospective Study on the Prognostic Impact of Pregnancy in Women With History of BRCA Mutated Breast Cancer

Jules Bordet Institute81 个研究点 分布在 23 个国家目标入组 4,732 人开始时间: 2017年1月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4,732
试验地点
81
主要终点
Disease-free Survival

研究概览

简要总结

The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosis of invasive breast cancer between January 2000 and December 2020;
  • Breast cancer diagnosis at the age of ≤ 40 years;
  • Known presence of germline BRCA mutation.

排除标准

  • Known BRCA mutation with no diagnosis of invasive breast cancer;
  • Diagnosis of ovarian cancer or other malignancies with no history of invasive breast cancer;
  • Diagnosis of hereditary or familiar invasive breast cancer without BRCA mutation or with BRCA genes not tested;
  • Diagnosis of invasive breast cancer with germline BRCA variants of unknown significance.

结局指标

主要结局

Disease-free Survival

时间窗: 10 years

The primary end points were the cumulative incidence of pregnancy and disease-free survival.

Cumulative Incidence of Pregnancy After Breast Cancer

时间窗: 10 years

The primary end points were the cumulative incidence of pregnancy and disease-free survival.

次要结局

  • Breast Cancer-Specific Survival(10 years)
  • Overall Survival(10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (81)

Loading locations...

相似试验

Safety of Pregnancy in BRCA Mutated Breast Cancer... | 临床试验